A comparative study of platelets behaviour in controls and acute myocardial infarction patients

N J Deshpande1, K R Rao

  • 1Department of Physiology, Government Medical College, Mysore.

Insights

Platelet activation is heightened in acute myocardial infarction patients, showing increased aggregation with ADP and epinephrine. This suggests a link between platelet hyperreactiveness and myocardial infarction, potentially involving platelet sequestration.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Vascular Biology

Background:

  • Acute myocardial infarction (AMI) is a major cause of vascular disease mortality.
  • Platelet-endothelial interactions are critical in the development of AMI.
  • Understanding platelet behavior in AMI is essential for therapeutic strategies.

Purpose of the Study:

  • To compare platelet aggregability between AMI patients and healthy controls.
  • To investigate the effect of AMI on peripheral platelet count.
  • To assess the differential response of platelet aggregation to agonists like ADP and epinephrine.

Main Methods:

  • Study involved 5 AMI patients from ICCU and 5 age-matched controls (40-60 years).
  • Platelet aggregability was measured using a Chronolog Dual Channel Aggrometer with adenosine diphosphate (ADP) and epinephrine as agonists.
  • Peripheral platelet counts were determined by hemocytometry and analyzed using Student's 't' test.

Main Results:

  • AMI patients exhibited a significantly increased platelet aggregation index compared to controls.
  • Platelet aggregation was more pronounced with ADP than with epinephrine in AMI patients.
  • A trend towards lower peripheral platelet counts was observed in AMI patients.

Conclusions:

  • Elevated platelet aggregability, particularly in response to ADP, is characteristic of AMI.
  • Relative thrombocytopenia in AMI may result from platelet sequestration in coronary microvasculature.
  • The balance between endothelium-derived relaxing factor (EDRF) and endothelium-derived constricting factor (EDCF) influences platelet activation in AMI.